175 related articles for article (PubMed ID: 31699519)
21. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
[TBL] [Abstract][Full Text] [Related]
22. Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.
Sicard A; Karras A; Goujon JM; Sirac C; Bender S; Labatut D; Callard P; Sarkozy C; Essig M; Vanhille P; Provot F; Nony A; Nochy D; Ronco P; Bridoux F; Touchard G
Nephrol Dial Transplant; 2014 Oct; 29(10):1894-902. PubMed ID: 24619059
[TBL] [Abstract][Full Text] [Related]
23. IgG heavy-chain deposition disease.
Katz A; Zent R; Bargman JM
Mod Pathol; 1994 Oct; 7(8):874-8. PubMed ID: 7838842
[TBL] [Abstract][Full Text] [Related]
24. Heavy chain deposition disease: an overview.
Oe Y; Soma J; Sato H; Ito S
Clin Exp Nephrol; 2013 Dec; 17(6):771-8. PubMed ID: 23652830
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease.
Masai R; Wakui H; Togashi M; Maki N; Ohtani H; Komatsuda A; Sawada K
Clin Nephrol; 2009 Jan; 71(1):9-20. PubMed ID: 19203545
[TBL] [Abstract][Full Text] [Related]
26. Cutis laxa for diagnosis of γ1-heavy-chain deposition disease: Report of four cases.
Chavarot N; Battistella M; Vignon M; Baron M; Girerd S; Jachiet M; Asli B; Galicier L; Malphettes M
J Dermatol; 2018 Oct; 45(10):1211-1215. PubMed ID: 30035313
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal Gammopathy of Renal Significance with Deposits of Infrequent Morphology: Two Case Reports of Light and Heavy Chain Deposition Disease with Atypical Presentation and Literature Review.
De La Flor JC; Monroy-Condori M; Apaza-Chavez J; Arenas-Moncaleano I; Díaz F; Guerra-Torres XE; Morales-Montoya JL; Lerma-Verdejo A; Sandoval E; Villa D; Vieru CM
Medicines (Basel); 2023 Oct; 10(10):. PubMed ID: 37887262
[TBL] [Abstract][Full Text] [Related]
28. Use of bortezomib in heavy-chain deposition disease: a report of 3 cases.
Patel K; Dillon JJ; Leung N; Bomback AS; Appel GB; D'Agati V; Canetta PA
Am J Kidney Dis; 2014 Jul; 64(1):123-7. PubMed ID: 24613055
[TBL] [Abstract][Full Text] [Related]
29. A mouse model recapitulating human monoclonal heavy chain deposition disease evidences the relevance of proteasome inhibitor therapy.
Bonaud A; Bender S; Touchard G; Lacombe C; Srour N; Delpy L; Oblet C; Druilhe A; Quellard N; Javaugue V; Cogné M; Bridoux F; Sirac C
Blood; 2015 Aug; 126(6):757-65. PubMed ID: 26113545
[TBL] [Abstract][Full Text] [Related]
30. C3 glomerulonephritis associated with monoclonal gammopathy: a retrospective case series study from a single institute in China.
Zhang X; Yu XJ; Li DY; Wang SX; Zhou FD; Zhao MH
Ren Fail; 2021 Dec; 43(1):1437-1445. PubMed ID: 34658305
[TBL] [Abstract][Full Text] [Related]
31. Immunoglobulin A Heavy Chain Deposition Disease: A Case Report.
Chen Q; Ye JB; Zhong Q
Iran J Kidney Dis; 2021 Dec; 15(6):457-460. PubMed ID: 34930858
[TBL] [Abstract][Full Text] [Related]
32. Immunoglobulin heavy chain gene rearrangement in heavy chain deposition disease suggests it is a plasma cell disease: a case report.
Rao Q; Xu R; Wan Q
J Int Med Res; 2022 Mar; 50(3):3000605221086428. PubMed ID: 35301906
[TBL] [Abstract][Full Text] [Related]
33. Proliferative glomerulonephritis with discrete deposition of monoclonal immunoglobulin γ1 CH 2 heavy chain and κ light chain: a new variant of monoclonal immunoglobulin deposition disease.
Komatsuda A; Ohtani H; Sawada K; Joh K; Wakui H
Pathol Int; 2013 Jan; 63(1):63-7. PubMed ID: 23356227
[TBL] [Abstract][Full Text] [Related]
34. [Heavy chain deposition disease: report of a case and review of the literature].
Imai H
Rinsho Byori; 2001 Jul; 49(7):695-8. PubMed ID: 11519134
[TBL] [Abstract][Full Text] [Related]
35. Gamma 1-heavy chain deposition disease accompanied by IgG kappa in serum, urine, and bone marrow.
Kaneko K; Seta K; Soma J; Kuwahara T; Koizumi M; Kikuchi Y; Sugawara A; Yahata K
CEN Case Rep; 2014 May; 3(1):44-48. PubMed ID: 28509245
[TBL] [Abstract][Full Text] [Related]
36. Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?
Bridoux F; Desport E; Frémeaux-Bacchi V; Chong CF; Gombert JM; Lacombe C; Quellard N; Touchard G
Clin J Am Soc Nephrol; 2011 Sep; 6(9):2165-74. PubMed ID: 21784830
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal gammopathy presenting as recurrent nephrotic syndrome: therapeutic implications.
Krishnan SG; Valderrama E; Wagner JD; Mattana J; Shah HH; Appel G; Singhal PC
Am J Med Sci; 2007 May; 333(5):313-6. PubMed ID: 17505177
[TBL] [Abstract][Full Text] [Related]
38. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
[TBL] [Abstract][Full Text] [Related]
39. Heavy chain deposition disease presenting with raised anti-GBM antibody levels; a case report.
Turner M; Crawford A; Winterbottom C; Flossmann O; Alchi B; Soares M; Bhandary U
BMC Nephrol; 2020 May; 21(1):175. PubMed ID: 32398029
[TBL] [Abstract][Full Text] [Related]
40. Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China.
Yu XJ; Zhang X; Li DY; Wang SX; Zhou FD; Zhao MH
Nephrology (Carlton); 2020 Mar; 25(3):202-211. PubMed ID: 31301197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
